Objective: To evaluate the prognostic usefulness of cerebrospinal fluid (CSF) lactate in postoperative bacterial meningitis (POBM) and to establish the optimal CSF lactate cut-off values in our population to identify POBM in neurosurgical patients. Patients and Methods: A prospective study of postoperative neurosurgical patients with presumed and established bacterial meningitis in the Department of Neurosurgery, NIMS, Hyderabad, India, from September 2012 to December 2014. The diagnostic and prognostic values of CSF lactate have been evaluated and compared with other well-established CSF markers. All the patients who have undergone intradural cranial surgery with features of meningism have been included. Results: The study included 37 patients. The CSF value of the first lumbar puncture (LP) was taken to evaluate the diagnostic value of CSF lactate. Twenty three corresponded to Group A, and 14 to Group B. The mean CSF lactate in Group A was 5.94 +/- 2.36, and in Group B 4.60 +/- 2.31. Subsequent LPs were performed and CSF analyzed to evaluate the prognostic value of CSF lactate. The CSF markers like neutrophil count (P = 0.003), CSF/blood glucose ratio (P = 0.012), CSF lactate (P = 0.024), lymphocyte count (P = 0.046), leukocyte count (P = 0.047) have shown their prognostic value in a descending order. CSF markers like the presence of red blood cells (P = 0.540) and proteins (P = 0.757) did not show prognostic significance. The decline in CSF lactate (content and concentration) after initiation of antibiotics correlated with subsidence of fever (P = 0.0001), decrease in neck rigidity (P = 0.022) and improvement in sensorium. They were also correlated improvement in CSF/blood glucose ratio and CSF white blood cell counts. Conclusions: In our study, CSF lactate was noted to have a dependable prognostic value in POBM. As routine CSF markers can be ambiguous in POBM, CSF lactate can be considered a better alternative for both establishing the diagnosis and prognostication.
机构:
Showa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Ichinose, Naoki
Yoshikawa, Gakushi
论文数: 0引用数: 0
h-index: 0
机构:
Showa Gen Hosp, Dept Neurosurg, 8-1-1 Hanakoganei, Kodaira, Tokyo 1878510, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Yoshikawa, Gakushi
Fukao, Eri
论文数: 0引用数: 0
h-index: 0
机构:
Showa Gen Hosp, Dept Neurol, 8-1-1 Hanakoganei, Kodaira, Tokyo 1878510, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Fukao, Eri
Takahata, Tomoaki
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Fac Pharm, I-5-30 Shibakoen,Minato Ku, Tokyo 1058512, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Takahata, Tomoaki
Ichisawa, Mai
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Fac Pharm, I-5-30 Shibakoen,Minato Ku, Tokyo 1058512, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Ichisawa, Mai
Enoki, Yuki
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Fac Pharm, I-5-30 Shibakoen,Minato Ku, Tokyo 1058512, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Enoki, Yuki
Taguchi, Kazuaki
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Fac Pharm, I-5-30 Shibakoen,Minato Ku, Tokyo 1058512, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Taguchi, Kazuaki
Oda, Toshimi
论文数: 0引用数: 0
h-index: 0
机构:
Showa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Showa Gen Hosp, Dept Infect Dis, 8-1-1 Hanakoganei, Kodaira, Tokyo 1878510, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Oda, Toshimi
Tsutsumi, Kazuo
论文数: 0引用数: 0
h-index: 0
机构:
Showa Gen Hosp, Dept Neurosurg, 8-1-1 Hanakoganei, Kodaira, Tokyo 1878510, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan
Tsutsumi, Kazuo
Matsumoto, Kazuaki
论文数: 0引用数: 0
h-index: 0
机构:
Keio Univ, Fac Pharm, I-5-30 Shibakoen,Minato Ku, Tokyo 1058512, JapanShowa Gen Hosp, Dept Infect Control & Prevent, Kodaira, Tokyo, Japan